The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[4-(3-Oxo-3H-[1,2]dithiol-4-yl)-phenoxy]-N-[4-(3-trifluoromethyl-phenylamino)-quinazolin-6-yl]-acetamie ID: ALA4791589
Chembl Id: CHEMBL4791589
PubChem CID: 162671649
Max Phase: Preclinical
Molecular Formula: C26H17F3N4O3S2
Molecular Weight: 554.58
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(COc1ccc(-c2cssc2=O)cc1)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1
Standard InChI: InChI=1S/C26H17F3N4O3S2/c27-26(28,29)16-2-1-3-17(10-16)33-24-20-11-18(6-9-22(20)30-14-31-24)32-23(34)12-36-19-7-4-15(5-8-19)21-13-37-38-25(21)35/h1-11,13-14H,12H2,(H,32,34)(H,30,31,33)
Standard InChI Key: FXWHQHVLSXRKQV-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 554.58Molecular Weight (Monoisotopic): 554.0694AlogP: 6.56#Rotatable Bonds: 7Polar Surface Area: 93.21Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.50CX Basic pKa: 3.98CX LogP: 5.97CX LogD: 5.97Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.22Np Likeness Score: -1.45
References 1. Zheng YG,Zhang WQ,Meng L,Wu XQ,Zhang L,An L,Li CL,Gao CY,Xu L,Liu Y. (2020) Design, synthesis and biological evaluation of 4-aniline quinazoline derivatives conjugated with hydrogen sulfide (HS) donors as potent EGFR inhibitors against L858R resistance mutation., 202 [PMID:32619886 ] [10.1016/j.ejmech.2020.112522 ]